日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/08/13 | 3,334 | 3,342 | 3,287 | 3,323 | -11 | -0.3% | 315,800 |
| 2025/08/12 | 3,337 | 3,347 | 3,281 | 3,334 | +44 | +1.3% | 321,700 |
| 2025/08/08 | 3,270 | 3,294 | 3,221 | 3,290 | +34 | +1% | 339,000 |
| 2025/08/07 | 3,301 | 3,336 | 3,225 | 3,256 | -58 | -1.8% | 394,000 |
| 2025/08/06 | 3,320 | 3,333 | 3,303 | 3,314 | +17 | +0.5% | 242,600 |
| 2025/08/05 | 3,320 | 3,337 | 3,295 | 3,297 | +3 | +0.1% | 190,000 |
| 2025/08/04 | 3,265 | 3,305 | 3,265 | 3,294 | -9 | -0.3% | 223,500 |
| 2025/08/01 | 3,288 | 3,318 | 3,278 | 3,303 | +26 | +0.8% | 277,700 |
| 2025/07/31 | 3,249 | 3,282 | 3,245 | 3,277 | +41 | +1.3% | 341,300 |
| 2025/07/30 | 3,209 | 3,263 | 3,192 | 3,236 | +27 | +0.8% | 432,300 |
| 2025/07/29 | 3,153 | 3,219 | 3,146 | 3,209 | +20 | +0.6% | 272,900 |
| 2025/07/28 | 3,199 | 3,227 | 3,173 | 3,189 | -10 | -0.3% | 295,300 |
| 2025/07/25 | 3,222 | 3,222 | 3,173 | 3,199 | -32 | -1% | 366,800 |
| 2025/07/24 | 3,250 | 3,296 | 3,230 | 3,231 | +11 | +0.3% | 664,100 |
| 2025/07/23 | 3,071 | 3,241 | 3,067 | 3,220 | +184 | +6.1% | 879,100 |
| 2025/07/22 | 3,099 | 3,136 | 3,020 | 3,036 | -72 | -2.3% | 576,300 |
| 2025/07/18 | 3,127 | 3,148 | 3,088 | 3,108 | -20 | -0.6% | 328,600 |
| 2025/07/17 | 3,060 | 3,135 | 3,051 | 3,128 | +81 | +2.7% | 397,700 |
| 2025/07/16 | 3,019 | 3,052 | 3,006 | 3,047 | +34 | +1.1% | 419,500 |
| 2025/07/15 | 3,030 | 3,055 | 2,994 | 3,013 | +8 | +0.3% | 711,800 |
| 2025/07/14 | 2,993 | 3,034 | 2,967 | 3,005 | -215 | -6.7% | 1,217,300 |
| 2025/07/11 | 3,175 | 3,249 | 3,175 | 3,220 | +70 | +2.2% | 309,500 |
| 2025/07/10 | 3,151 | 3,159 | 3,117 | 3,150 | ±0 | ±0% | 331,600 |
| 2025/07/09 | 3,122 | 3,179 | 3,118 | 3,150 | +32 | +1% | 271,200 |
| 2025/07/08 | 3,090 | 3,127 | 3,081 | 3,118 | +28 | +0.9% | 284,900 |
| 2025/07/07 | 3,130 | 3,130 | 3,090 | 3,090 | -43 | -1.4% | 229,500 |
| 2025/07/04 | 3,141 | 3,158 | 3,124 | 3,133 | -8 | -0.3% | 240,700 |
| 2025/07/03 | 3,134 | 3,161 | 3,122 | 3,141 | +21 | +0.7% | 268,000 |
| 2025/07/02 | 3,146 | 3,151 | 3,120 | 3,120 | -21 | -0.7% | 279,800 |
| 2025/07/01 | 3,175 | 3,177 | 3,119 | 3,141 | -5 | -0.2% | 473,900 |
| 2025/06/30 | 3,130 | 3,159 | 3,120 | 3,146 | +28 | +0.9% | 636,100 |
| 2025/06/27 | 3,101 | 3,128 | 3,095 | 3,118 | -3 | -0.1% | 529,500 |
| 2025/06/26 | 3,116 | 3,126 | 3,100 | 3,121 | +1 | ±0% | 533,700 |
| 2025/06/25 | 3,111 | 3,132 | 3,074 | 3,120 | +16 | +0.5% | 802,400 |
| 2025/06/24 | 3,111 | 3,140 | 3,087 | 3,104 | +10 | +0.3% | 836,800 |
| 2025/06/23 | 3,333 | 3,349 | 3,094 | 3,094 | -306 | -9% | 1,155,400 |
| 2025/06/20 | 3,421 | 3,436 | 3,391 | 3,400 | -42 | -1.2% | 241,400 |
| 2025/06/19 | 3,500 | 3,500 | 3,430 | 3,442 | -73 | -2.1% | 156,600 |
| 2025/06/18 | 3,512 | 3,541 | 3,509 | 3,515 | -8 | -0.2% | 113,900 |
| 2025/06/17 | 3,546 | 3,572 | 3,523 | 3,523 | -44 | -1.2% | 116,100 |
| 2025/06/16 | 3,644 | 3,644 | 3,567 | 3,567 | -79 | -2.2% | 167,000 |
| 2025/06/13 | 3,660 | 3,660 | 3,613 | 3,646 | -28 | -0.8% | 108,900 |
| 2025/06/12 | 3,705 | 3,722 | 3,650 | 3,674 | -23 | -0.6% | 159,300 |
| 2025/06/11 | 3,670 | 3,751 | 3,661 | 3,697 | +152 | +4.3% | 263,600 |
| 2025/06/10 | 3,552 | 3,575 | 3,529 | 3,545 | -31 | -0.9% | 126,000 |
| 2025/06/09 | 3,567 | 3,582 | 3,534 | 3,576 | +42 | +1.2% | 123,900 |
| 2025/06/06 | 3,535 | 3,561 | 3,510 | 3,534 | +30 | +0.9% | 171,600 |
| 2025/06/05 | 3,534 | 3,534 | 3,494 | 3,504 | -30 | -0.8% | 89,900 |
| 2025/06/04 | 3,510 | 3,544 | 3,510 | 3,534 | +15 | +0.4% | 121,700 |
| 2025/06/03 | 3,554 | 3,554 | 3,478 | 3,519 | -31 | -0.9% | 192,800 |
1～
50
件表示中 / 3761件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 332,300円 | +3.6% | -15.3% | 3.73% | 9.33倍 | 0.91倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 433,600円 | +5.8% | +1.2% | 2.77% | 14.04倍 | 1.12倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 359,200円 | +3.8% | -19.9% | 3.79% | 11.67倍 | 0.89倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 199,700円 | +5.9% | +684.6% | 2.75% | 13.26倍 | 1.33倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 155,400円 | +5.0% | +1.5% | 0.00% | 13.30倍 | 3.74倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
